- Home
- AAOI vs PHAR Comparison
AAOI vs PHAR Comparison
Compare AAOI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAOI
- PHAR
- Stock Information
- Founded
- AAOI 1997
- PHAR 1988
- Country
- AAOI United States
- PHAR Netherlands
- Employees
- AAOI N/A
- PHAR N/A
- Industry
- AAOI Semiconductors
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- AAOI Technology
- PHAR Health Care
- Exchange
- AAOI Nasdaq
- PHAR Nasdaq
- Market Cap
- AAOI 707.6M
- PHAR 587.5M
- IPO Year
- AAOI 2013
- PHAR N/A
- Fundamental
- Price
- AAOI $14.67
- PHAR $10.03
- Analyst Decision
- AAOI Buy
- PHAR Strong Buy
- Analyst Count
- AAOI 4
- PHAR 3
- Target Price
- AAOI $25.50
- PHAR $30.00
- AVG Volume (30 Days)
- AAOI 3.1M
- PHAR 3.0K
- Earning Date
- AAOI 05-08-2025
- PHAR 05-08-2025
- Dividend Yield
- AAOI N/A
- PHAR N/A
- EPS Growth
- AAOI N/A
- PHAR N/A
- EPS
- AAOI N/A
- PHAR N/A
- Revenue
- AAOI $308,551,000.00
- PHAR $320,708,000.00
- Revenue This Year
- AAOI $113.56
- PHAR $12.39
- Revenue Next Year
- AAOI $64.07
- PHAR $9.84
- P/E Ratio
- AAOI N/A
- PHAR N/A
- Revenue Growth
- AAOI 50.30
- PHAR 24.13
- 52 Week Low
- AAOI $6.70
- PHAR $6.65
- 52 Week High
- AAOI $44.50
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- AAOI 53.00
- PHAR 71.76
- Support Level
- AAOI $13.31
- PHAR $8.60
- Resistance Level
- AAOI $15.40
- PHAR $10.28
- Average True Range (ATR)
- AAOI 1.15
- PHAR 0.30
- MACD
- AAOI 0.55
- PHAR 0.17
- Stochastic Oscillator
- AAOI 85.52
- PHAR 88.79
About AAOI Applied Optoelectronics Inc.
Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.